Preventing birth defects: The value of the NBDPS case-control approach
- PMID: 26172859
- DOI: 10.1002/bdra.23404
Preventing birth defects: The value of the NBDPS case-control approach
Abstract
Birth Defect Registries provide a basis for epidemiological research into risk factors, thus facilitating a growing understanding of what causes congenital anomalies and how one might target preventive public health actions and reduce inequalities. The National Birth Defects Prevention Study (NBDPS) has used 10 U.S. registries as a basis for a large case-control study. This commentary reviews its methodology and selected areas of output. The strengths of NBDPS lie in the quality of diagnostic coding and classification of birth defects and its size. The sources of bias in NBDPS data relate particularly to retrospective exposure ascertainment entailing a long period of recall, incomplete ascertainment of terminations of pregnancy for fetal anomaly, and unknown bias in case selection. NBDPS results have shown the protective effect of healthy dietary patterns, but have not been as informative as expected in relation to furthering understanding of the protective effect of folic acid. NBDPS medication studies are making important contributions to addressing the gap in existing evidence systematically across a wide range of birth defects, but are challenged by the quality of information on exposure, dose and underlying disease condition, and the interpretation of results of multiple testing. Studies of environmental contaminants in collaboration with experts in exposure assessment have linked addresses to residential exposure measures, using the advantages of information on residential history and confounders, but are challenged by the need to consider exposure mixtures. NBDPS could increase its public health impact by placing more emphasis on socioeconomic inequalities.
Keywords: birth defects; case-control; risk factors.
© 2015 Wiley Periodicals, Inc.
Similar articles
-
Guidelines for case classification for the National Birth Defects Prevention Study.Birth Defects Res A Clin Mol Teratol. 2003 Mar;67(3):193-201. doi: 10.1002/bdra.10012. Birth Defects Res A Clin Mol Teratol. 2003. PMID: 12797461
-
Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS).Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):733-40. doi: 10.1002/bdra.23373. Epub 2015 Apr 6. Birth Defects Res A Clin Mol Teratol. 2015. PMID: 25846741 Free PMC article.
-
Clinician reviewers in birth defects surveillance programs: survey of the National Birth Defects Prevention Network.Birth Defects Res A Clin Mol Teratol. 2006 Nov;76(11):781-6. doi: 10.1002/bdra.20282. Birth Defects Res A Clin Mol Teratol. 2006. PMID: 17051528
-
The National Birth Defects Prevention Study: A review of the methods.Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):656-69. doi: 10.1002/bdra.23384. Epub 2015 Jun 2. Birth Defects Res A Clin Mol Teratol. 2015. PMID: 26033852 Free PMC article. Review.
-
Paper 3: EUROCAT data quality indicators for population-based registries of congenital anomalies.Birth Defects Res A Clin Mol Teratol. 2011 Mar;91 Suppl 1:S23-30. doi: 10.1002/bdra.20779. Epub 2011 Mar 7. Birth Defects Res A Clin Mol Teratol. 2011. PMID: 21384530 Review.
Cited by
-
Protocol of a prospective and multicentre China Teratology Birth Cohort (CTBC): association of maternal drug exposure during pregnancy with adverse pregnancy outcomes.BMC Pregnancy Childbirth. 2021 Sep 1;21(1):593. doi: 10.1186/s12884-021-04073-0. BMC Pregnancy Childbirth. 2021. PMID: 34470618 Free PMC article.
-
Population-based birth defects data in the United States, 2008 to 2012: Presentation of state-specific data and descriptive brief on variability of prevalence.Birth Defects Res A Clin Mol Teratol. 2015 Nov;103(11):972-93. doi: 10.1002/bdra.23461. Birth Defects Res A Clin Mol Teratol. 2015. PMID: 26611917 Free PMC article. No abstract available.
-
Review: Hormone Pregnancy Tests Were Teratogenic by the Same Failed Abortion and Hypoxia-Related Mechanism as Misoprostol.Birth Defects Res. 2025 Mar;117(3):e2462. doi: 10.1002/bdr2.2462. Birth Defects Res. 2025. PMID: 40084490 Free PMC article. Review.
-
Descriptive and risk factor analysis of nonsyndromic sacral agenesis: National Birth Defects Prevention Study, 1997-2011.Am J Med Genet A. 2019 Sep;179(9):1799-1814. doi: 10.1002/ajmg.a.61290. Epub 2019 Jul 11. Am J Med Genet A. 2019. PMID: 31294918 Free PMC article.
-
Editorial perspectives from the founding CDC leadership of the National Birth Defects Prevention study.Birth Defects Res A Clin Mol Teratol. 2015 Aug;103(8):649-51. doi: 10.1002/bdra.23393. Epub 2015 Jun 10. Birth Defects Res A Clin Mol Teratol. 2015. PMID: 26069218 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous